- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:20 | VITURA HEALTH LIMITED: Proposed issue of securities - VIT | 3 | ASX | ||
| 02:09 | VITURA HEALTH LIMITED: Change in substantial holding | 2 | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| Di | VITURA HEALTH LIMITED: Proposed issue of securities - VIT | - | ASX | ||
| Di | VITURA HEALTH LIMITED: Vitura JV acquires assets of Releaf Group | 2 | ASX | ||
| Mo | VITURA HEALTH LIMITED: Cleansing Notice - section 708A(5) | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
| 29.10. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 27.10. | VITURA HEALTH LIMITED: Strategy Reset delivers positive Q1 results | - | ASX | ||
| 25.10. | VITURA HEALTH LIMITED: Updated Proxy Form | - | ASX | ||
| 23.10. | VITURA HEALTH LIMITED: Shareholder statement | 2 | ASX | ||
| 23.10. | VITURA HEALTH LIMITED: Board renewal and Notice of 2024 AGM | 1 | ASX | ||
| 21.10. | VITURA HEALTH LIMITED: 2024 Annual Report | - | ASX | ||
| 16.10. | VITURA HEALTH LIMITED: Vitura settles dispute with Code4 Cannabis | - | ASX | ||
| 09.09. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 08.09. | VITURA HEALTH LIMITED: Appointment of Chief Technology Officer | - | ASX | ||
| 06.09. | VITURA HEALTH LIMITED: Date for 2024 Annual General Meeting | - | ASX | ||
| 06.09. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 04.09. | VITURA HEALTH LIMITED: Investor presentation | - | ASX | ||
| 03.09. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 29.08. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX |
Seite:
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 4,008 | -0,50 % | Aurora Cannabis Inc (3): Aurora Cannabis releases new recreational products | ||
| TILRAY BRANDS | 1,233 | +0,28 % | Tilray Brands, Inc.: Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt | NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter... ► Artikel lesen | |
| ORGANIGRAM | 1,424 | +0,71 % | Organigram Reports Third Quarter Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter... ► Artikel lesen | |
| SNDL | 1,836 | -1,56 % | Cannabis company SNDL to repurchase up to CA$100 million in stock | ||
| MYDECINE INNOVATIONS GROUP | 0,003 | 0,00 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen | |
| BIONANO GENOMICS | 0,209 | 0,00 % | Bionano Genomics: Bionano Announces Preliminary 3Q 2024 Revenues and Cash | SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects revenue... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 0,190 | 0,00 % | Tonix Pharmaceuticals Holding: Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments | This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations... ► Artikel lesen | |
| HIGH TIDE | 2,515 | +0,40 % | High Tide eröffnet dritte Canna Cabana-Filiale in Hamilton (Ontario) | CALGARY, AB, 18. November 2024 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA) - ein erfolgreiches und auf den Einzelhandel ausgerichtetes... ► Artikel lesen | |
| JAGUAR HEALTH | 0,965 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Family Company Napo Therapeutics Named "Best Pharmaceuticals Innovator of the Year - Europe" | Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription drug, in Europe for orphan and/or rare diseases SAN... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 4,045 | -0,98 % | Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline | SEATTLE and VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.10.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 24.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.10.2024ISIN NameAU0000114977 BOOKTOPIA... ► Artikel lesen | |
| MEDIPHARM LABS | 0,043 | -6,55 % | MediPharm Labs Corp.: MediPharm Labs Reports Third Quarter Results | Strong Growth in International GMP Medical Markets
TORONTO, Nov. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm"... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,104 | -15,45 % | Argent Biopharma - Valuation report | We value Argent at an un-risked net present value (NPV) of US$1.1bn. Adjusting for the company's specified probabilities of success (PoS) for its three clinical programmes gives a risk-adjusted NPV... ► Artikel lesen | |
| AUSCANN | - | - | AUSCANN GROUP HOLDINGS LTD: Removal from Official List - Annual Listing Fees | ||
| NABRIVA THERAPEUTICS | - | - | Meitheal gains rights to CONTEPO from Nabriva in North America |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,046 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.
